Offer - Urjas Oil for just ₹ 1 X
Gibtulio Met 12.5/1000 Tablet is a commercial drug that is prescribed in the form of Tablet. Diabetes Type 2 are some of its major therapeutic uses.
The right dosage of Gibtulio Met 12.5/1000 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Gibtulio Met 12.5/1000 Tablet include Respiratory tract infection, Nausea or vomiting. While these are the most often observed Gibtulio Met 12.5/1000 Tablet side effects, there are can be others also. These have been listed below. These side effects of Gibtulio Met 12.5/1000 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Gibtulio Met 12.5/1000 Tablet's effect during pregnancy is Severe and Moderate while nursing. It is important to know if Gibtulio Met 12.5/1000 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gibtulio Met 12.5/1000 Tablet related warnings section.
Gibtulio Met 12.5/1000 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Gibtulio Met 12.5/1000 Tablet in conditions like Kidney Disease, Diabetes Type 1. Other contraindications of Gibtulio Met 12.5/1000 Tablet have been discussed in the sections ahead.
Drug reaction of Gibtulio Met 12.5/1000 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Gibtulio Met 12.5/1000 Tablet is safe while driving, and is is addictive in nature.
Gibtulio Met 12.5/1000 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gibtulio Met 12.5/1000 Tablet safe for pregnant women?
Gibtulio should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Gibtulio Met 12.5/1000 Tablet safe during breastfeeding?
Gibtulio can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Gibtulio Met 12.5/1000 Tablet on the Kidneys?
Gibtulio rarely affects the kidneys.
What is the effect of Gibtulio Met 12.5/1000 Tablet on the Liver?
Using Gibtulio does not have any harmful effects on the liver.
What is the effect of Gibtulio Met 12.5/1000 Tablet on the Heart?
Gibtulio has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Gibtulio Met 12.5/1000 Tablet unless your doctor advises you to do so -
Is this Gibtulio Met 12.5/1000 Tablet habit forming or addictive?
Gibtulio Met 12.5/1000 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Gibtulio Met 12.5/1000 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Gibtulio Met 12.5/1000 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Gibtulio Met 12.5/1000 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Gibtulio Met 12.5/1000 Tablet
It is safe to take Gibtulio Met 12.5/1000 Tablet with food.
Interaction between Alcohol and Gibtulio Met 12.5/1000 Tablet
Taking Gibtulio Met 12.5/1000 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jardiance® (empagliflozin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 491-493